ABSTRACT
Objective: The Italian Society for Pediatric Infectious Diseases created a registry on children with infective endocarditis (IE) hospitalized in Italy.
Methods: A cross-sectional survey was conducted on patients hospitalized due to IE in Italian paediatric wards between January 1, 2000, and June 30, 2015.
Results: Over the 15-year study period, 47 IE episodes were observed (19 males; age range, 2-17 years). Viridans Streptococci were the most common pathogens among patients with predisposing cardiac conditions and Staphylococcus aureus among those without (37.9% vs. 5.5%, p = 0.018, and 6.9% vs. 27.8%, p = 0.089, respectively). Six of the 7 (85.7%) S. aureus strains were methicillin-resistant. The majority of patients with and without predisposing cardiac conditions recovered without any complications.
Conclusion: In Italy, paediatric IE develops without any previous predisposing factors in a number of children, methicillin-resistant S. aureus has emerged as a common causative agent and the therapeutic approach is extremely variable.
Financial & competing interests disclosure
This study was supported in part by grants from the Italian Ministry of Health (Ricerca Corrente 2015 850/01, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
In Italy, rheumatic heart disease is no longer a common predisposing factor for infective endocarditis (IE) development.
Despite the fact that congenital heart disease remains a substantial cause of IE in a number of children, IE often develops without any predisposing factors.
viridans streptococci are the main etiological agents in children with predisposing cardiac disease, whereas methicillin-resistant S. aureus has emerged as a common causative agent in children without predisposing cardiac disease.
Treatment options recommended for pediatric IE did not follow precise therapeutic schemes, and therapeutic approaches are extremely variable.
Considering the rate of mortality in the absence of predisposing cardiac disease, specific therapeutic management protocols for IE in pediatric patients are urgently needed.